Community pharmacist experiences of providing needle and syringe programmes in Ireland
Community pharmacists are increasingly acknowledged as under-utilized, important and accessible health providers in providing harm reduction support to drug users via needle and syringe programmes (NSP), provision of advice, HIV/Hepatitis testing and as referral mechanism to social, medical and trea...
Saved in:
Published in | Research in social and administrative pharmacy Vol. 13; no. 4; pp. 767 - 777 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Community pharmacists are increasingly acknowledged as under-utilized, important and accessible health providers in providing harm reduction support to drug users via needle and syringe programmes (NSP), provision of advice, HIV/Hepatitis testing and as referral mechanism to social, medical and treatment services. We report here on qualitative findings as part of the evaluation of the pilot Pharmacy Needle Exchange (PNEX) programme in Ireland.
The aim was to understand and illustrate pharmacist experiences of providing NSP.
Of the 107 eligible pharmacies, a total of 70 participated in the national evaluation. Telephone interviews (n = 17) and one-to-one interviews (n = 13) using a semi-structured guide were conducted with 30 pharmacists. Analysis of data was conducted using the Empirical Phenomenological Psychological (EPP) five step protocol.
Pharmacist experiences illustrated the largely positive nature of providing NSP, and highlighted needs to develop harm reduction training for pharmacists and appropriate strategies to raise awareness, provide exchange packs to meet the specific needs of the diverse populations of people who inject drugs and ensure the development of trusting relationships and opportunities to engage within a confidential service.
Further enhancement of NSP coverage and targeted service delivery within national care pathways for drug and alcohol services is warranted. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1551-7411 1934-8150 |
DOI: | 10.1016/j.sapharm.2016.07.006 |